(Q42373626)

28 October 2017

The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis (English)

1 reference

28 October 2017

Cuzick J

1

1 reference

28 October 2017

Cooper EH

series ordinal

2

1 reference

28 October 2017

MacLennan IC

series ordinal

3

1 reference

28 October 2017

language of work or name

English

0 references

publication date

1 July 1985

1 reference

British Journal of Cancer

28 October 2017

1 reference

28 October 2017

52

1 reference

28 October 2017

1

1 reference

28 October 2017

1-6

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1985.140

28 October 2017

0 references

cites work

Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

Beta 2-microglobulin: an old molecule assumes a new look

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

Evaluation of serum β 2-microglobulin as a prognostic indicator in myelomatosis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

Serum β 2-microglobulin in myelomatosis: potential value in stratification and monitoring

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

Serum β2-microglobulin in various disorders

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

Beta 2 microglobulin in pathology. Introduction

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

Beta2-microglobulin levels of serum and ascites in malignant diseases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

β2-Microglobulin levels in cancerous and other disease states

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977159

beta 2 Microglobulin, a tumour marker of lymphoproliferative disorders

29 May 2018

1 reference

12 December 2020

Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical status

1 reference

12 December 2020

Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging

1 reference

12 December 2020

Prognostic significance of pretreatment serum β2-microglobulin levels in multiple myeloma

1 reference

12 December 2020

Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients

1 reference

12 December 2020

Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1985.140

1 reference

28 October 2017

1 reference

28 October 2017

PubMed publication ID

3893505

1 reference